FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with ...
Under pressure, prosecutors cut deal with Wilmington's 'Butter,' drug 'empire' co-defendants
Under attacks about the integrity of a sprawling 2019 drug racketeering case, prosecutors cut a deal with men it described as ...
FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.
Nature16h
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
History Exposes a Crucial Flaw in RFK Jr.’s Vision for Treating Drug Addiction
Kennedy wants to create "wellness drug rehabilitation farms." But the U.S. tried it before, and it didn't work.
The best exercises to do while taking weight loss drugs
If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...
Novo Nordisk will test CagriSema's long-term efficacy in late-stage trial, clinicaltrials.gov entry shows
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.
STAT1d
MASH drugs reach a meaningful tipping point for patients and investors
Akero's success in reversing cirrhosis follows that of Madrigal, making analysts and investors bullish on drugs to treat ...
Long-COVID patients are frustrated that federal research hasn’t found new treatments
Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.
How drug overdose deaths have plagued one generation of Black men for decades
Young Black men in cities across America died of drug overdoses at high rates in the 1980s and 1990s. During the recent fentanyl crisis, older Black men in many cities have been dying at unusually ...